DrugPatentWatch Database Preview
XANAX XR Drug Profile
or, see our see our flat-rate plans
When do Xanax Xr patents expire, and when can generic versions of Xanax Xr launch?
The generic ingredient in XANAX XR is alprazolam. There are fifteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Summary for XANAX XR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 43 |
| Patent Applications: | 4,449 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | XANAX XR at DailyMed |
Pharmacology for XANAX XR
| Ingredient-type | Benzodiazepines |
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for XANAX XR
Synonyms for XANAX XR
| 08H |
| 12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene |
| 12-CHLORO-3-METHYL-9-PHENYL-2,4,5,8-TETRAAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,8,11,13-HEXAENE |
| 28981-97-7 |
| 3u5j |
| 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl- |
| 4H-(1,2,4)Triazolo(4,3-alpha)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl- |
| 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-1-methyl-6-phenyl- |
| 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-1-methyl-6-phenyl- |
| 4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl- |
| 51339-48-1 |
| 8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
| 8-Chloro-1-methyl-6-(phenyl-d5)-4H-(1,2,4)triazolo[4,3-a][1,4]benzodiazepine |
| 8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
| 8-Chloro-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepine |
| 8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine |
| 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine |
| 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-alpha)(1,4)benzodiazepine |
| 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 8-chloro-6-phenyl-1-methyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine |
| 981A977 |
| A819702 |
| AC-18721 |
| AC1L1CYL |
| ACN-036616 |
| AK339386 |
| AKOS005066050 |
| Alcelam |
| Algad |
| Alpaz |
| Alphapharm Brand of Alprazolam |
| Alplax |
| Alpram |
| Alprax |
| alprazolam |
| Alprazolam (JP15/USP/INN) |
| Alprazolam (JP17/USP/INN) |
| Alprazolam [USAN:INN:BAN:JAN] |
| Alprazolam [USAN:USP:INN:BAN:JAN] |
| Alprazolam 0.1 mg/ml in Methanol |
| Alprazolam 1.0 mg/ml in Methanol |
| Alprazolam Alphapharm Brand |
| Alprazolam Apotex Brand |
| Alprazolam extended release tablets |
| Alprazolam intensol |
| Alprazolam Kenral Brand |
| Alprazolam Novopharm Brand |
| Alprazolam Nu-Pharm Brand |
| Alprazolam Orion Brand |
| Alprazolam Pfizer Brand |
| Alprazolam solution |
| Alprazolam solution, 1 mg/mL in methanol, analytical standard, for drug analysis |
| Alprazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| Alprazolam Temmler Brand |
| Alprazolam, European Pharmacopoeia (EP) Reference Standard |
| Alprazolamum |
| Alprazolamum [INN-Latin] |
| Alprazolan |
| Alpronax |
| Alprox |
| Alviz |
| Alzam |
| Alzolam |
| Alzon |
| Anpress |
| AP-1002 |
| API0001427 |
| Apo Alpraz |
| Apo-Alpraz |
| ApoAlpraz |
| Apotex Brand of Alprazolam |
| Arzneimittelwerk Dresden Brand of Alprazolam |
| AZ-002 |
| Azor |
| BBL028160 |
| BC226242 |
| BDBM50001728 |
| Bestrol |
| BIDD:GT0475 |
| BIDD:PXR0150 |
| Bio-0790 |
| BRD-K32398298-001-01-4 |
| BRN 1223125 |
| C06817 |
| CAS-28981-97-7 |
| Cassadan |
| CCG-100855 |
| CHEBI:2611 |
| CHEMBL661 |
| Constan |
| CPD000149316 |
| D 65MT |
| D-65MT |
| D00225 |
| D0L9GG |
| D65MT |
| DB00404 |
| DEA No. 2882 |
| DR001286 |
| DSSTox_CID_2577 |
| DSSTox_GSID_22577 |
| DSSTox_RID_76639 |
| DTXSID4022577 |
| EINECS 249-349-2 |
| Esparon |
| Frontal |
| FT-0658560 |
| Gen-Alprazolan |
| GTPL7111 |
| Helex |
| HMS2051A10 |
| HMS3393A10 |
| HSDB 7207 |
| I14-7472 |
| Intensol |
| Kenral Brand of Alprazolam |
| Ksalol |
| LS-156344 |
| MCULE-1215564244 |
| Mialin |
| MLS000559000 |
| MLS000759485 |
| MLS001423979 |
| NC00105 |
| NCGC00159466-02 |
| NCGC00159466-03 |
| Neurol |
| Niravam |
| Niravam (TN) |
| Novo Alprazol |
| Novo-Alprazol |
| NovoAlprazol |
| Novopharm Brand of Alprazolam |
| NSC-760140 |
| NSC760140 |
| Nu Alpraz |
| Nu Pharm Brand of Alprazolam |
| Nu-Alpraz |
| Nu-Pharm Brand of Alprazolam |
| NuAlpraz |
| Orion Brand of Alprazolam |
| Panistat |
| Panix |
| Pfizer Brand of Alprazolam |
| Pharmakon1600-01502395 |
| Pharnax |
| PL053252 |
| Prazam |
| Prazolan |
| Prinox |
| Ralozam |
| Relaxol |
| Restyl |
| SAM001246696 |
| SCHEMBL8398 |
| SMR000149316 |
| Solanax |
| Staccato-alprazolam |
| STK590494 |
| Tafil |
| Tafil D |
| Temmler Brand of Alprazolam |
| Tensivan |
| TGAR01P |
| Tox21_111692 |
| Tranax |
| Trankimazin |
| Tranquinal |
| Tricalma |
| Tus 1 |
| TUS-1 |
| U 31889 |
| U-31,889 |
| U-31889 |
| U31,889 |
| UNII-YU55MQ3IZY |
| Unilan |
| Valeans |
| VREFGVBLTWBCJP-UHFFFAOYSA-N |
| W-107015 |
| Xanagis |
| Xanax |
| Xanax (TN) |
| Xanax TS |
| Xanolam |
| Xanor |
| Xanor (TN) |
| YU55MQ3IZY |
| Zacetin |
| Zanapam |
| Zaxan |
| ZB000199 |
| Zenax |
| ZINC903 |
| Zolam |
| Zolan |
| Zolarem |
| Zoldac |
| Zoldax |
| Zopax |
| Zopic |
| Zotran |
US Patents and Regulatory Information for XANAX XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-001 | Jan 17, 2003 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-004 | Jan 17, 2003 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-002 | Jan 17, 2003 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Expired US Patents for XANAX XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-004 | Jan 17, 2003 | ➤ Sign Up | ➤ Sign Up |
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-001 | Jan 17, 2003 | ➤ Sign Up | ➤ Sign Up |
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | ➤ Sign Up | ➤ Sign Up |
| Pharmacia And Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-002 | Jan 17, 2003 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
or, see our see our flat-rate plans
